Viruses aren't just disease agents any more. Scientists now know they can be used in therapies for cancer but concerns over the safety of 'oncolytic viruses' remain because they can also damage healthy tissues.
But Mayo Clinic researchers say they have discovered a way of controlling the viruses behind potential cancer therapeutics by engineering the virus's genetic sequence, using microRNAs to restrict them to specific tissues. The microRNAs destabilize the virus's genome, making it impossible for the virus to run amok. The discovery is reported in the current issue of Nature Medicine.
MicroRNAs are the nucleotide snippets that are encoded by genes, but don't end up as proteins. In many cases, they have a role in down-regulating different cellular genes. In this case, a virus is engineered to be responsive to microRNAs that are present in certain cell types. Using this new form of targeting, researchers redirected a virus normally responsible for a lethal muscle infection to recognize only cancer cells. The laboratory mice that received the engineered virus were cured of established tumors and suffered no ill effects.
"Our findings demonstrate a new tool for molecular medicine that should also help allay concern over the use of viruses as a therapeutic delivery system," says Stephen Russell, M.D., Ph.D., Mayo physician-scientist and lead author of the study.
Significance of the research
Most viruses can infect different cell types, which leads to the array of symptoms during a viral infection. Now as viruses are being engineered for use as vaccines, cancer therapeutics and gene therapy vectors, researchers want to restrict and redirect the types of cells they do (or don't) infect as additional safeguards against disease. The target sequences of microRNAs used in the study kept the virus from destroying muscle cells while allowing viral replication to proceed in cancer cells allowing the virus to completely cure mice with melanoma.
The Mayo researchers say microRNA target insertion may be a new way to make viruses safer for use in cancer therapy and could lead to new methods of making safer vaccines.
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Case For Moon: Gateway For Open Ended, Exploraton, With Planetary Protection Central - On The SpaceShow
- Why We Get Tired When We Stay Up Too Late
- Sweet Irony: The Environmental Impacts Of GMO Sugar Science Denial
- We’re Not In Europe Any More: BfR Statement On EDCs Embraces The Risk-Based Approach
- The Real Cost Of Milk
- Even Light Drinkers Should Watch For Fatty Liver Disease
- Deep Learning Enters The Beauty Industry
- "Hello Dario,no copies are made of the same event - the triggering and the data storage are two..."
- "Yes, as the numbers are averages, there is this possibility - actually it happens all the time..."
- "Climate change has been affected by Al-Nino...."
- "And: Comparative efficacy of homeopathic and allopathic systems of medicine in the management of..."
- "It is not nonsense, it is fact. Do some research. If you and others were correct there should,..."
- Silencing cholera's social media
- More than half of EU citizens questioned now think e-cigarettes are harmful
- DIY sampling kits accessed through gay men's social media unearth new HIV cases
- 'Suggestive evidence' for link between air pollution and heightened stillbirth risk
- Prohibition 2016: Assessing the UK's Psychoactive Substances Act